BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 23107094)

  • 21. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular progression to cervical precancer, epigenetic switch or sequential model?
    Nedjai B; Reuter C; Ahmad A; Banwait R; Warman R; Carton J; Boer S; Cuzick J; Lorincz AT
    Int J Cancer; 2018 Oct; 143(7):1720-1730. PubMed ID: 29679470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer.
    He C; Xu C; Xu M; Yuan Y; Sun Y; Zhao H; Zhang X
    Int J Gynecol Pathol; 2012 May; 31(3):280-5. PubMed ID: 22498947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
    Heselmeyer-Haddad K; Sommerfeld K; White NM; Chaudhri N; Morrison LE; Palanisamy N; Wang ZY; Auer G; Steinberg W; Ried T
    Am J Pathol; 2005 Apr; 166(4):1229-38. PubMed ID: 15793301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of hTERC gene amplification detection by FISH in the screening of cervical lesions.
    Zhang Y; Wang X; Ma L; Wang Z; Hu L
    J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):368-71. PubMed ID: 19513624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of human telomerase RNA component gene by fluorescent in situ hybridization for screening of cervical lesions].
    Gao L; Zhu Y; Liu SP; Gao Y; Zhu MH
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):104-7. PubMed ID: 21426806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment and analysis of the prediction model for cervical squamous cell carcinoma.
    Zhou YH; Fan WF; Deng J; Xi HL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5042-5048. PubMed ID: 29228452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.
    Hu T; Yang P; Zhu H; Chen X; Xie X; Yang M; Liu S; Wang H
    Diagn Pathol; 2015 Apr; 10():20. PubMed ID: 25885042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia.
    Takac I; Arko D; Kodric T; Poljak M; Zagorac A; Erjavec-Skerget A; Kokalj-Vokac N
    J Int Med Res; 2009; 37(5):1588-95. PubMed ID: 19930867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
    Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
    Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
    Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
    Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective study of hTERC gene detection by fluorescence in situ hybridization (FISH) in cervical intraepithelial neoplasia 1 natural prognosis.
    Li L; Jiang W; Zeng SY; Li L
    Eur J Gynaecol Oncol; 2014; 35(3):289-91. PubMed ID: 24984543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection.
    Zejnullahu VA; Zejnullahu VA; Josifovska S; Vukovik N; Pakovski K; Panov S
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Dec; 38(3):143-151. PubMed ID: 29668478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA.
    Snijders PJ; van Duin M; Walboomers JM; Steenbergen RD; Risse EK; Helmerhorst TJ; Verheijen RH; Meijer CJ
    Cancer Res; 1998 Sep; 58(17):3812-8. PubMed ID: 9731489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of Van-Clear and xylene in the detection of cervical hTERC gene by fluorescence in situ hybridization].
    Chen Z; Wang Y; Mi X; Chen A; Zhong S; Huang H; Xu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):367-73. PubMed ID: 27241146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles.
    Tian R; Cui Z; He D; Tian X; Gao Q; Ma X; Yang JR; Wu J; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Zhong H; Fan W; Chen Y; Jin Z; Cao C; Yu M; Xie W; Huang Z; Bao Y; Xie H; Yao S; Hu Z
    Carcinogenesis; 2019 Oct; 40(10):1220-1228. PubMed ID: 31102403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.
    Tsezou A; Oikonomou P; Kollia P; Mademtzis I; Kostopoulou E; Messinis I; Vamvakopoulos N
    Exp Biol Med (Maywood); 2005 Apr; 230(4):263-70. PubMed ID: 15792948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.